Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study

Kritiya Butthongkomvong,1 Nilubol Raunroadroong,2 Sirikul Sorrarichingchai,2 Isaraporn Sangsaikae,3 Vichien Srimuninnimit,4 Henrik Harling,5 Stig Larsen6 1Udonthani Cancer Hospital, Udonthani, Thailand; 2Lampang Cancer Hospital, Lampang, Thailand; 3Ubonratchathani Cancer Hospital, Ubonratchathani, T...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Butthongkomvong K, Raunroadroong N, Sorrarichingchai S, Sangsaikae I, Srimuninnimit V, Harling H, Larsen S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Benzene-polycarboxylic acid complex BP-C1 low dose cisplatin breast cancer stage IV hormone receptors randomised double blind Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/5f0834f35ca64ae8a912ce2e77fea5de
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study

Ejemplares similares